Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1, NEJM 2022, 20.9% mean weight loss at 72 weeks) Mayo Clinic Prescription weight-loss drugs FDA DailyMed (current GLP-1 prescribing information) MeAgain App Store listing What MeAgain users say about progress What Our Users Say I've been using the app for about 7 months now and I love how I'm able to track my meals and my daily medication
drafted the manuscript, and all the other authors helped to revise it
Therefore, the glycaemic improvement in animals treated with a GLP-1R/GcgR co-agonist is attributable to body-weight-independent and -dependent effects
These compounds influence collagen production, metabolism, hormone balance, and recovery, making them an exciting option for those looking to improve energy levels, skin health, sleep quality, and muscle maintenance
If plain water tastes off, try infusing it with cucumber, mint, or berries
Less common: Temporary skin discoloration at the injection site